TrialCancer immunology, immunotherapy : CII2020

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.

Amir Khammari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.